Long-term Effect of Transcranial Magnetic Stimulation and Transcranial Electrical Stimulation in Primary Progressive Aphasia: Randomized, Double-blind Clinical Trial (RECONNECT-PLUS)
Led by Hospital San Carlos, Madrid · Updated on 2026-04-23
80
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
Researchers are investigating how different non-invasive brain stimulation methods affect the progression of primary progressive aphasia (PPA) over six months. The study compares three types of brain stimulation—Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), and a combination of both—against a sham (placebo) stimulation. All participants will also receive language therapy, as PPA mainly impacts language abilities and daily functioning.
Transcranial Magnetic Stimulation follows an intermittent theta-burst protocol targeting the left dorsolateral prefrontal cortex, while Transcranial Electrical Stimulation uses an excitatory approach over the same area. Each brain stimulation session is guided by neuronavigation. Language therapy, based on the lexical retrieval cascade protocol, is provided immediately after each brain stimulation session. Treatment lasts six months, starting with an intensive period of 10 daily sessions over two weeks, followed by weekly maintenance sessions for 22 weeks.
Participants will undergo assessments throughout the study, including language and cognitive tests such as the Mini-Linguistic State Examination, naming trained words, ACE-III, and neuropsychiatric inventories, all measured at six months. Brain imaging with FDG-PET will also be performed. Researchers will monitor how language abilities and daily living activities change during the study. Safety and progress will be tracked with regular evaluations to understand the long-term effects of these brain stimulation techniques on PPA.
CONDITIONS
Brief Title
Long Term Effect of Brain Stimulation in PPA
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Diagnosis of primary progressive aphasia (PPA) based on current consensus criteria with progressive language impairment as main cause of decline
Diagnosis of one of the three PPA variants (non-fluent, semantic, logopenic) supported by neuroimaging
Clinical Dementia Rating scale score of 1 or less
Language impairment is the main neurological deficit for the patient
You will not qualify if you...
Diagnosis of conditions other than PPA causing language impairment
History of epilepsy or epileptiform EEG pathology
Contraindications for TMS or tDCS such as ferromagnetic material, pregnancy, or breastfeeding
Terminal illness or active cancer
Alcohol or substance abuse in the past year
Major psychiatric disorders including schizophrenia, bipolar disorder, OCD, or personality disorders
Absolute inability to communicate or poor language command preventing participation
Severe PPA preventing participation in interventions or assessments
Participation in another clinical trial within previous 4 months
Chronic use of medications that could affect study outcomes except stable antiepileptics, benzodiazepines, cholinesterase inhibitors, and SSRIs as specified
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 6 months
Participants receive brain stimulation sessions using transcranial magnetic or electrical stimulation combined with language therapy immediately after each session.
10 consecutive daily sessions over 2 weeks followed by weekly sessions for 22 weeks
Long-term effect of transcranial magnetic stimulation and transcranial electrical stimulation in primary progressive aphasia: study protocol for a randomised, double-blind clinical trial (RECONNECT-PLUS).
Lucía Fernández-Romero, María Díez-Cirarda, Cristina Delgado-Alonso...